Task: Answer the multiple-choice question.
Question: Which drug exhibits a 4.363\% hERG inhibition at 1uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a) O=C(CSc1nnc(Cc2cccs2)n1Cc1ccco1)Nc1ccc(Br)cc1
b) Cc1cc(N/N=C/c2ccc(O)cc2O)nc(N2CCOCC2)n1
Answer: b. Cc1cc(N/N=C/c2ccc(O)cc2O)nc(N2CCOCC2)n1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1cc(N/N=C/c2ccc(O)cc2O)nc(N2CCOCC2)n1
Cc1cc(N/N=C/c2ccc(O)cc2O)nc(N2CCOCC2)n1
4-[(E)-[(6-methyl-2-morpholin-4-ylpyrimidin-4-yl)hydrazinylidene]methyl]benzene-1,3-diol